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ABSTRACT
Production of extracellular vesicles (EVs) involved in intercellular communication is a common
capacity of most cell types. Upon encountering opsonized microorganisms, neutrophilic granu-
locytes release EVs that compromise bacterial growth. We carried out a systematic investigation
of the involvement of potential opsonin receptors in EV-generation from human and murine
neutrophils. Applying flow cytometric, proteomic and functional analysis as well as using geneti-
cally modified mice, we demonstrate that formation of antibacterial EVs depends upon stimula-
tion of the multifunctional Mac-1 integrin complex, also called as complement receptor 3 (CR3),
whereas activation of immunoglobulin binding Fc receptors or pattern recognition receptors
alone or in combination is ineffective. Mac-1/CR3 stimulation and downstream tyrosine kinase
signalling affect both the numbers, the cargo content and the antibacterial capacity of the
produced vesicles. In contrast, Mac-1/CR3 signalling is not required for spontaneous EV formation,
clearly indicating the existence of separate molecular pathways in EV biogenesis. We propose
that EVs are “tailor-made” with different composition and functional properties depending on the
environmental circumstances.
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Introduction
Extracellular vesicles (EVs) represent a recently discov-
ered channel of intercellular communication signifi-
cantly affecting, among others immune cell functions
[1–3]. Cells of evolutionarily very different species,
such as mammals, plants or microorganisms were all
shown to produce EVs spontaneously and/or upon
stimulation [4,5]. However, the released EVs are het-
erogeneous both in size, composition and mechanism
of generation [6,7]. Exosomes released from multivesi-
cular bodies are small, have a diameter of (or less than)
100 nm, are sedimented by centrifugal force around
100,000g and they are enriched in certain endosome
markers, such as CD63, CD9 and CD81 tetraspanins
[1,7–9]. EVs originating from the cell surface by bud-
ding or blebbing are often referred to as “microvesi-
cles” or “ectosomes” [4,10]. This population may
contain both small (d ˂100 nm), medium-size
(d = 100 nm–1 µm) and large (d > 1 µm) vesicles
that can be separated at different centrifugal forces
[7]. Composition of these vesicles reflects the
composition of the parent cell, containing components
both from the plasma membrane, cytosol and even
certain subcellular organelles [1].
There are several indications that EV production
and/or composition depend on environmental factors.
Stimuli, such as lipopolysaccharide for murine dendri-
tic cells [11], IgE for murine mast cells [12] or T-cell
receptor stimulation of CD4+ T-cells [13] alter the size,
floatation properties or protein composition of exo-
somes. In case of the larger-sized EV, population
alteration of the composition and/or effects of the
released EVs are triggered in neutrophilic granulocytes
by chemotactic agent and adhesion [14], in HUVEC
cells by high glucose environment and angiotensin II
[15] or in rat basophil leukaemia cells by expression of
proteinase-3 [16]. However, the molecular mechanisms
underlying these alterations are unknown.
In our previous work, we showed that stimulation of
neutrophilic granulocytes (PMN) with opsonized parti-
cles (bacteria or zymosan A) triggered the formation of
large amount of medium-sized EVs enriched in granule
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proteins. EVs issued from activated cells had a definitive
dose-dependent antibacterial effect and were named
“aEV”s [17,18]. Binding of bacteria and prevention of
their proliferation were also observed with EVs derived
from peripheral blood mononuclear cells upon bacterial
stimulation [19]. Prevalence of aEVs in the serum of
septic patients suggested the in vivo relevance of the
process [18,20], and measurement of “microvesicle–bac-
teria aggregation” was proposed as a diagnostic tool for
sepsis [21]. In detailed analysis of PMN-derived EVs, we
demonstrated that aEVs present a protein distribution
profile different both from spontaneously formed EVs
(sEV) and EVs generated upon apoptosis of PMN [22].
In the current study, we investigated EV biogenesis
in human and in genetically modified murine neutro-
phils upon physiological stimuli. We revealed the role
of the multifunctional molecule Mac-1/CR3 in trigger-
ing the release of antibacterial EVs and in altering
cargo sorting. Our data provide an initial example for
environmental factors selectively directing generation
of EVs via specific cell surface receptors.
Materials and methods
Materials
Hanks' balanced salt solution (HBSS) with calcium, mag-
nesium and glucose was from GE Healthcare Life
Sciences (South Logan, UT, USA), zymosan A, ferricyto-
chrome c (horse heart, type VI) and superoxide dismu-
tase (SOD) were from Sigma-Aldrich (St. Louis, MO,
USA), Ficoll-Paque and Percoll from GE Healthcare
Bio-Sciences AB (Uppsala, Sweden), HEPES (pH 7.4)
from Sigma. All other used reagents were of research
grade. Green fluorescent protein (GFP) expressing and
chloramphenicol resistant S. aureus (USA300) was a kind
gift of Professor William Nauseef (University of Iowa).
DNAse I was from Thermo Scientific (Waltham, MA,
USA) and was used in 100 U/mL final concentration.
Dasatinib (> 99% pure) was obtained from Selleck
Chemicals and its purity and stability was confirmed by
HPLC-MS analysis (Vichem, Hungary). Dasatinib was
dissolved in DMSO. The final dasatinib-treated samples
contained ≤0.002% DMSO and inhibitor-free controls
contained 0.002% DMSO.
Preparation of human PMN and EV
Venous blood samples were drawn from healthy adult
volunteers according to procedures approved by the
National Ethical Committee (ETT-TUKEB No. BPR/
021/01563-2/2015). Neutrophils were obtained by dex-
tran sedimentation followed by a 62.5% (v/v) Ficoll
gradient centrifugation (700g, 40 min, 22°C) as pre-
viously described [22]. The preparations contained
more than 95% PMN and less than 0.5% eosinophils.
PMNs (typically 107 cell in 1 mL HBSS) were incubated
with or without activating agent for 30 min at 37°C in a
linear shaker (80 rpm/min). After activation, cells were
sedimented (500g, Hermle Z216MK 45° fixed angle
rotor, 5 min, 4°C). Upper 500 µL of the supernatant
was filtered through a 5 µm pore sterile filter (Sterile
Millex Filter Unit, Millipore, Billerica, MA, USA). The
filtered fraction was sedimented (15,700g, Hermle
Z216MK 45° fixed angle rotor, 5 min, 4°C) and the
pellet was carefully resuspended in the original incuba-
tion volume. Where indicated, PMNs were pretreated
with dasatinib in 200 nM final concentration for
10 min at room temperature. Protein concentration of
EV was determined by the Bradford protein assay
using bovine serum albumin as standard [18].
Test of neutrophil extracellular trap (NET)
formation and cell viability during activation of
PMN
Viability and NET formation was controlled by con-
focal microscopy (Zeiss LSM710 confocal laser scan-
ning microscope equipped with EC Plan-Neoflural,
Zeiss 20x/0.5 M27 objective). Excitation and emission
wavelengths were 514 and 534–709 nm, respectively.
Similar to other experiments, 5 × 106 PMNs in 500 µL
HBSS were incubated on the cover slip at 37°C in the
presence of the indicated stimuli and the nucleic acid
stain propidium iodide (1 g/mL, Invitrogen, USA).
PMA at a concentration of 100 nM was used as positive
control. Samples were analysed at 20 and 180 min. Per
sample six regions of interest were investigated with
ZEN software (Zeiss). Parallel to microscopy, propi-
dium iodide fluorescence of differently activated PMN
(107/mL) was followed in a CLARIOstar microplate
reader (BMG Labtech, Germany) at 535 nm excitation
and 617 nm emission wavelength. Reaction volume was
200 µL at 37°C by a gentle linear shaking (80 rpm/
min). FITC conjugated AnnexinV (BD Biosciences,
USA) and propidium iodide positivity of PMNs was
measured by flow cytometry after 20 min activation.
Triton X-100 (0.1%) treated cells were used as positive
control.
Transgenic mice
Used mice strains are described in detail in previous
publications: CD18-deficient (Itgb2tm2Bay/tm2Bay, referred
to as CD18−/−) [23] were obtained from A. Beaudet
(Baylor College of Medicine, Houston, TX). FcRγ-chain
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deficient (Fcer1gtm1Rav/tm1Rav, referred to as FcRγ−/−)
mice were purchased fromTaconic [24]. CD11b-deficient
(Itgamtm1Myd/tm1Myd, referred to as CD11b−/−) mice were
purchased from The Jackson Laboratory. All transgenic
mice were backcrossed to the C57BL/6J genetic back-
ground for at least six generations. All transgenic mice
were 11–20 weeks old. Age- and sex-matched C57Bl/6J
animals were used as controls. Genotyping was per-
formed by allele-specific PCR. Wild type (WT) control
C57BL/6J mice were purchased fromCharles River or the
Hungarian National Institute of Oncology. Mice were
kept in sterile, individually ventilated cages (Tecniplast,
Buguggiate, Italy) in a conventional facility. All animal
experiments were approved by the Animal Care
Committee of the National Authority for Animal Health
(Budapest, Hungary).
Isolation of murine PMN and EV
Murine neutrophils were isolated from the bone mar-
row of the femurs, humeri and tibias of intact mice.
Because of the smaller size, a different protocol was
applied than for human PMN. Following hypotonic
lysis, Percoll gradient centrifugation (62.5% v/v, 700g,
40 min, 22°C) was carried out, using sterile and endo-
toxin-free reagents as previously described [25]. Cells
were kept at room temperature in Ca2+ and Mg2+-free
medium until use (usually less than 30 min) and pre-
warmed to 37°C before activation. Neutrophil assays
were performed at 37°C in HBSS supplemented with
Ca2+ and Mg2+ and 20 mM HEPES, pH 7.4. PMNs (107
cell in 1 mL HBSS) were incubated with or without
activating agent for 30 min at 37°C on a linear shaker
(80 rpm/min). After incubation, PMNs were sedimen-
ted (1000g, Hermle Z216MK 45° fixed angle rotor,
5 min, 4°C) and the upper 800 μL of the supernatant
was filtered through a 5 μm pore sterile filter. The
filtered fraction was sedimented again (30,000g,
Beckmann JA-17 fixed 25° angle rotor, 30 min, 4°C).
The sediment was resuspended in HBSS at the original
volume and used immediately for further analysis
according to previous observations [26].
Opsonization
Zymosan (5 mg in 1 mL HBSS) was opsonized with
500 μL pooled human or murine serum for 30 min at
37°C. For complement-free opsonization zymosan (5 mg
in 1 mL PBS) was opsonized with 500 μL human serum
pretreated with 20 mM EDTA. After opsonization, zymo-
san was centrifuged (2500g, 5 min, 4°C, Hermle Z216MK
45° fixed angle rotor), and washed once in HBSS.
Bacteria (OD600 = 1.0 in 800 μL HBSS) were opso-
nized with 200 μL pooled human serum for 30 min at
37°C. After opsonization, bacteria were centrifuged
(5000g, 10 min, 4°C, Hermle Z216MK 45° fixed angle
rotor), and washed once in HBSS.
Activation of adherent neutrophils
Selective activation of Mac-1 complex of adherent human
neutrophils was performed in six well tissue culture plates
(Biofil, Hungary) coated overnight with 0.2 mg/mL BSA
or 50 μg/mL C3bi (both from Merck, Darmstadt,
Germany) as previously described [27]. To obtain immo-
bilized immune complex–coated surfaces, human lacto-
ferrin (20 μg/mL; Sigma-Aldrich, USA) was covalently
linked to poly-l-lysine (Sigma-Aldrich, USA) coated six
well plates and then treated with polyclonal anti-lactofer-
rin (LTF) IgG (1:400 dilution; Sigma-Aldrich, USA) or
non-specific IgG (1:400 dilution; Sigma-Aldrich, USA) for
1 h as previously described [28]. Unbound immunoglo-
bulin was removed by washing the plate by HBSS three
times. The isotype control serves to test the unspecific
binding of applied antibodies. As a control of cell activa-
tion, measurement of ROS production was performed
parallel to EV production [29]. Briefly, cells (106/mL)
were suspended in HBSS containing 100 μM cytochrome
c. The cells were stimulated with the indicated stimuli.
Control samples contained 20 μg/mL SOD. As positive
control 100 nM PMA was used. Aliquots (200 μL) of the
suspension were added into wells of a 96-well plate and
prewarmed at 37°C for 5 min in a shaking ELISA-reader
(Labsystems iEMS Reader MF). The changes in the
absorption were recorded at 550 nm for 30 min with 1
measurement/min at 37°C with gentle shaking. After
subtracting the background values, superoxide production
was presented as OD changes (Figure S3n–o).
Measurement of IL-8 production
PMN were left unstimulated or were activated by 0.5 or
0.25 mg/mL serum opsonized zymosan A. After two
hours, cells were pelleted with 500g for 10 min and in the
supernatant IL-8 was measured by sandwich ELISA kit
Human IL-8/CXCL8 DuoSet ELISA (R&D Systems,
Minneapolis, MN, USA), according to the manufacturer’s
protocol [30].
EV analysis and quantification by flow cytometry
Human EVs were labelled with PE conjugated mono-
clonal anti-CD11b (1 μg/mL, Tonbo Biosciences, USA,
Clone M1/70) [31], or FITC conjugated AnnexinV (BD
Biosciences) for 20 min at 37°C and then washed in
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HBSS. Murine EVs were labelled with PE conjugated
monoclonal anti-CD11b (1 μg/mL, Tonbo Biosciences,
USA, clone M1/70) [32] or PE conjugated monoclonal
anti-CD18 (1 μg/mL, BD Biosciences, clone C71/16)
[33] or PerCP-Cy 5.5 conjugated monoclonal anti-Ly6g
(1 μg/mL, BD Biosciences, clone 1A8) [34] or FITC
conjugated AnnexinV (BD Biosciences) for 20 min at
37°C and then washed in HBSS. Isotype controls were
from identical manufacturer, annexinV labelling was
controlled in 20 mM EDTA containing medium.
For flow cytometric detection, a Becton Dickinson
FACSCalibur flow cytometer was used with the fol-
lowing settings (for PE labelled EV detection Figures 1
and S1): flow rate was held under 1000 events/s;
FSC = E01 (log); SSC = 330V (log); 585/42 nm detec-
tor (Fl-2) = 550V (log). The procedure of measure-
ment is summarized in Figure 1. Pure HBSS medium
was used for setting the threshold (typical value: 152)
to eliminate instrumental noise (Figure 1(a)). In the
next step, fluorescent beads (3.8 μm SPHERO
Rainbow Alignment Particles from Spherotech Inc.,
USA) were detected to set the upper size limit of EV
detection range (Figure 1(b)). The smallest fluorescent
particles reliably detected by a conventional cytometer
could be around 300 nm [35]. After the measurement
of an EV preparation (Figure 1(c)) the number of
isotype control events (Figure 1(d)) and the 0.1%
Triton X-100 detergent non-sensitive events (Figure
1(e)) were subtracted to calculate the true EV number.
To avoid swarm detection, the flow rate was held
below 1000 events/s (3750 events/µL) during mea-
surements. Samples were re-measured after a two-
fold dilution which resulted in a mean ratio of
0.4977 (n = 292) as compared to the original sample,
with 95% confidence intervals of 0.495–0.5003, indi-
cating in a one-sample t test no significant difference
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Figure 1. Gating strategy of flow cytometric (FC) EV detection. Representative dot plots of FC measurements. a. Fluorescence
threshold was set in pure HBSS in the yellow fluorescence channel (585 nm) against forward scatter plot. b. Spherotech beads (3.8
μm) were used to set the upper size limit of EV gate. c. Representative dot plot of CD11b PE labelled EV. d. Representative dot plot
of isotype PE antibody labelled EV. e. Representative dot plot of 0.1% Triton X-100 treated CD11b PE labelled EV. f. Relation of EV
count to serial dilution. The x axis indicates the final volume used for resuspension of the sedimented EVs. Three representative
measurements. The arrows indicate the dilution used routinely.
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from the hypothetical value of 0.5. Linearity of mea-
surements was also controlled in a broader range
Figure 1(f) and S1, arrows in Figure 1(f) indicate the
two dilutions measured routinely). In all FC measure-
ments 16 μL of sample was analysed and corrected to
calculate the true EV count by subtracting the Triton
X-100 resistent and the isotype antibody labelled
events. The true EV count was multiplied by 62.5 or
125 (depending on the pellet resuspension volume of
0.5 resp. 1.0 mL) to calculate EV count in the whole
1000 μL volume that contained EVs derived from 107
PMNs. FC data were analysed with Flowing 2.5
Software (Turku Centre for Biotechnology, Finland).
Quality control of the EV preparation by size
exclusion chromatography (SEC)
Following the principles of MISEV2018 [36], the EV
preparation was validated by size exclusion chromato-
graphy (SEC). Sepharose CL-2B (GE Healthcare;
Uppsala, Sweden) was stacked in empty polypropylene
columns containing 30 μm pore size porous polyethy-
lene filter (ThermoFischer Scientific, USA). The pre-
pared columns had 1.6 cm diameter and 6.5 cm height
with 13 mL total bed volume. Neutrophils (107 cells/mL
HBSS) were sedimented (500g, Hermle Z216MK 45°
fixed angle rotor, 5 min, 4°C) and the supernatant was
filtered through a 5 µm pore sterile filter onto the top of
the SEC column. A maximal volume of 1.5 mL was
loaded on the column, followed by elution with HBSS
(pH 7.4). The eluate was collected in 22 sequential frac-
tions of 0.5 mL. Each fraction was analysed by dynamic
light scattering (DLS), flow cytometry and western blot-
ting. For western blotting, fractions were centrifuged
(15,700g, Hermle Z216MK 45° fixed angle rotor,
5 min, 4°C) and the pellet was carefully resuspended in
30 µL distilled water and 10 μL Laemmli sample buffer.
Indicated fractions were resuspended in 50 μL distilled
water for Bradford protein measurements and in 500 μL
HBSS for bacterial survival assay. After every separation,
SEC columns were regenerated [37] and were not used
more than 5 times.
As shown in Figure S2, fractions 8 through 12 con-
tained EVs detectable by DLS both in the sEV (Figure
S2a) and in the aEV (Figure S2b) preparations. In these
fractions, EVs were detected also by flow cytometry
and the number of aEVs was consistently higher than
sEV numbers (Figure S2c). In the fractions SEC8-12
the major granule protein lactoferrin and in most of
the fractions also actin could be revealed by western
blotting. The increase of protein content observed in
aEV preparation affected only the protein recovered in
the vesicular (SEC8-12) fractions, whereas the amount
of co-sedimented protein recovered in fractions
SEC13-22 was not changed (Figure S2e).
Dynamic light scattering (DLS)
DLS measurements were performed at room tempera-
ture with an equipment consisting of a goniometer
system (ALV GmbH, Langen, Germany), a diode-
pumped solid-state laser light source (Melles Griot
58-BLS-301, 457 nm, 150 mW) and a light detector
(Hamamatsu H7155 PMT module). The evaluation
software yielded the autocorrelation function of scat-
tered light intensity, which was further analysed by the
maximum entropy method (MEM), from where the
different contributions of this function were deter-
mined. The radius of the particles was calculated
using sphere approximation [22].
Transmission electron microscopy (TEM)
EV-containing pellets were processed as described in
our previous papers [18,22]. Briefly, pelleted EVs were
fixed with 4% paraformaldehyde at room temperature
for 1 h, rinsed by PBS and postfixed in 1% osmium
tetroxide (OsO4) for 20 min. After rinsing with distilled
water, pellets were dehydrated by a series of increasing
ethanol concentrations, including block staining with
1% uranyl-acetate in 50% ethanol for 30 min, finally
embedded in Taab 812 (Taab; Aldermaston, UK).
Following polymerization at 60°C for 12 h, 50–60 nm
ultrathin sections were cut using a Leica UCT ultra-
microtome (Leica Microsystems, UK) and examined
using a Hitachi 7100 transmission electron microscope
(Hitachi Ltd., Japan).
Electron micrographs were made by Veleta 2k × 2k
MegaPixel side-mounted TEM CCD camera
(Olympus). Contrast/brightness of electron micro-
graphs was edited by Adobe Photoshop CS4 (Adobe
Systems Incorporated, CA, USA). Analysis of micro-
graphs was performed in ImageJ [38] by two skilled
persons independently. Data originate from 400 EVs
pro samples mean diameter was calculated from mea-
sured area.
Immunoblotting
EVs were lysed in Laemmli sample buffer (252 mM Tris-
HCl, 40% glycerine, 8% sodium dodecyl sulphate, 0.04%
bromephenol blue, 4% β-mercaptoethanol, pH 6.8),
boiled, run in 10% (w/v) polyacrylamide gels and trans-
ferred to nitrocellulosemembranes. After blocking for 1 h
in PBS containing 5% ovalbumin and 0.1% (w/v) Tween
20, blots were incubated with anti-lactoferrin polyclonal
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antibody [39] in 1:1000 dilution or anti-β-actin mAb
(clone AC-74, both from Merck, Darmstadt, Germany)
in 1:10,000 dilution or with anti-MPO monoclonal anti-
body (clone 2C7, Cell Signalling Technologies, Leiden,
The Netherlands) in 1:500 dilution in 5% ovalbumin.
Bound antibody was detected with enhanced chemilumi-
nescence using horseradish peroxidase linked whole anti-
rabbit-IgG (from donkey) or anti-mouse-IgG (from
sheep) secondary antibodies (both from GE Healthcare,
Little Chalfont, Buckinghamshire, UK) used in 1:5000
dilution.
Proteomic analysis
Mass spectrometry based proteomics was carried out
on EVs isolated in two biological replicates. In each
case, the isolated vesicles were resuspended in 35 µL
water. Protein concentration of each preparation was
determined using the Bradford assay. Proteins were
extracted using repeated freeze-thaw cycles [40], and
digested in solution using Trypsin/LysC mix (Promega,
Madison, WI) at 1:100 ratio for 1 h, followed by
Trypsin addition at 1:10 ratio for 2 h, both at 37°C.
The resulting peptides were desalted using Pierce™ C18
spin columns (Thermo Fisher Scientific, Waltham,
MA) and analysed on a Dionex Ultimate 3000
RSLCnano system (Thermo Fisher Scientific,
Waltham, MA) coupled to a Bruker Maxis II Q-TOF
mass spectrometer (Bruker, Bremen, Germany)
equipped with a CaptiveSpraynanoBooster ionization
source. A 2 cm 100 µm i.d. Nano Trap column packed
with Acclaim PepMap100 C18 (Thermo Fisher
Scientific, Waltham, MA) material was used for trap-
ping. Separation of the peptides was achieved on an
Acquity M-Class BEH130 C18 analytical column
(1.7 µm, 75 µm × 250 mm Waters, Milford, MA,
USA) using gradient elution (4–50% eluent B in 120
min). Solvent A was water + 0.1% formic acid, while
solvent B was acetonitrile + 0.1% formic acid. Data
were recalibrated using the Compass Data Analysis
software 4.3 (Bruker Daltonics, Bremen, Germany)
and processed with ProteinScape 3.0 software (Bruker
Daltonik GmbH, Bremen, Germany). Protein identifi-
cation was performed using the Mascot search engine
version 2.5 (Matrix Science, London, UK) against the
Swissprot database (2015_08) applying the following
search parameters: trypsin enzyme, 7ppm peptide
mass tolerance, 0.05 Da fragment mass tolerance,
max. 2 missed cleavages. Carbamidomethylation of
cysteines was set as fixed modification, while deamida-
tion (NQ) and oxidation (M) as variable modifications.
Proteins with a minimum of two identified, unique
peptides were accepted. False discovery rate (FDR)
was <1%. Gene ontology enrichment was performed
using FunRich [41]. Label-free quantification was per-
formed using MaxQuant [42] software version 1.5.3.30.
Each LC-MS/MS run was aligned using the “match
between runs” feature (match time window 0.8 min,
alignment time window 15 min).
Bacterial survival assay
Opsonized bacteria (5 × 107/50 μL HBSS) were added
to 500 μL EV (derived from 5 × 106 PMN) suspended
in HBSS. During a 40 min coincubation step at 37°C,
the bacterial count decreases or increases depending on
the samples’ antibacterial effect and the growth of
bacteria. At the end of the incubation, 2 mL ice-cold
stopping solution (1 mg/mL saponin in HBSS) was
added to stop the incubation and lyse EVs. After a
freezing step at −80°C for 20 min, samples were thawed
to room temperature and inoculated into LB broth.
Bacterial growth was followed as changes in OD
using a shaking microplate reader (Labsystems iEMS
Reader MF, Thermo Scientific) for 8 h, at 37°C, at
650 nm. After the end of growth phase, the initial
bacterial counts were calculated indirectly using an
equation similar to PCR calculation, as described pre-
viously [17].
Peritonitis
Abdominal cavity of WT or CD11b˗/˗ mice was injected
with zymosan dissolved in 500 μL PBS (0.2 μg/mL).
Two hours later animals were sacrificed and the peri-
toneum was washed with 5 mL ice-cold PBS.
Abdominal EVs were isolated as described above;
cells were analysed from the pellet of the first centrifu-
gation (1000g, Hermle Z216MK 45° fixed angle
rotor, 5 min, 4°C). Abdominal cells were identified by
FC using anti-Ly6g, FSC and SSC characteristics. EVs
were stained with FITC labelled annexinV or PE
labelled anti CD18 (1 μg/mL, BD Biosciences, clone
C71/16) and enumerated with flow cytometry as
described above.
Statistics
Comparisons between groups were analysed by two-
tailed Student’s t tests or ANOVA. Exact statistical tests
are indicated in the figure legends. All bar graphs show
mean and ± s.e.m. Difference was taken significant if P
value was <0.05. * represents P < 0.05; ** represents
P < 0.01; *** represents P < 0.0001. Statistical analysis
was performed using GraphPad Prism 6 for Windows
(La Jolla, California, USA).
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Results
Fc and complement receptors participate
differently in initiation of aEV production
In our earlier experiments, we observed that opsonized
particles initiated the formation of EVs which impaired
bacterial growth. In contrast, soluble mediators such as
FMLF, TNFα, CXCL12 or LPS had only weak effect on
EV formation, and those vesicles were devoid of antibac-
terial effect [18]. Our previous data thus indicated opso-
nin receptors as potential initiators of aEV formation
[43]. Therefore, we tested first the effect of stimulation
of the receptors of the two major classes of opsonins
present in blood plasma, immunoglobulins and comple-
ment components. Neutrophilic granulocytes express
several types of Fcγ receptors which recognize immun-
globulin G (IgG) [28] and complement receptors CR1,
CR3 and CR4 that recognize various complement frag-
ments [44, 45, 46].
EV formation in human PMNs was quantitatively
followed by two parallel methods: number of vesicles
detectable by flow cytometry and total protein content
of the separated vesicle population. Similar to previous
observations, stimulation of PMN with particles opso-
nized with full human serum induced a significant
increase in EV production marked as “aEV” compared
to sEV (Figure 2(a)). We controlled that neutrophil extra-
cellular trap (NET) formation did not occur and the
viability of the cells did not deteriorate during the
20 min incubation period (Figure S3). PMN activated
with opsonized zymosan were able to produce the soluble
mediator IL-8 as well as superoxide (Figure S3m,n). It
should also be recalled that in our previous study [18] we
did not observe any significant difference in the number,
the proportion of erythrosin B positive cells, or in the
ability of producing superoxide or kill bacteria between
control and opsonized bacteria treated neutrophils.
To assess the contribution of the different opsonin
receptors and potential pattern recognition receptors
(PRR), we measured EV formation upon stimulation of
PMNwith incompletely opsonized particles. As shown in
Figure 2(a), non-opsonized zymosan induced slight but
significant increase of EV production (marked “zEV”).
Particles opsonized in complement-depleted serum – that
contains only antibodies as functional opsonin – brought
about an EV production (marked “abzEV”) that did not
exceed the amount of zEV and remained definitely lower
than initiated by fully opsonized particles. The detectable
number and protein content of EVs increased propor-
tionally, unlike in case of EV generation in apoptotic
PMN, where abundant increase of EV number, but only
slight increase of protein content was observed previously
[22]. These observations suggest that the two types of
opsonin receptors may play different roles in aEV
generation.
To test the involvement of the two opsonin receptor
types separately and independently from phagocytosis,
we used relevant adhesive surfaces. Participation of Fc
receptors in EV formation was investigated on immune
complex surface but we did not observe significant
increase of EV generation as compared to the control
where Fc receptors are not activated (Figure 2(b)). In
parallel experiments, we verified that neutrophils adher-
ent to the immune complex surface were able to produce
superoxide (Figure S3o), indicating that activation of the
Fc receptors did take place and the lack of EV production
increase was not the result of missing cell activation. Next
we examined the potential role of complement receptors.
On neutrophils the dominant complement receptors are
CR3 and CR4, which belong to the family of β2 integrins
and can be specifically activated by the complement frag-
ment C3bi [44]. As shown in Figure 2(c), adding human
PMN on a C3bi surface resulted in a significant increase
in the number of detectable EVs. Thus, activation of the
complement receptors is effective in EV biogenesis also in
the absence of phagocytosis.
Next we compared the antibacterial effect of EVs pro-
duced upon different stimulation (Figure 2(d)). EVs pro-
duced spontaneously (sEV), or upon stimulation with non-
opsonized zymosan (zEV) or with zymosan opsonized only
by antibodies in complement-depleted serum (abzEV) had
no effect upon bacterial growth. Only full serum opsonized
zymosan evoked aEV were able to impair bacterial growth.
In previous experiments, we showed that the difference
between sEV and aEV in their effect on bacterial growth
was significant both when EVs from equal cell number or of
equal total protein were tested [18]. Separation by SEC was
applied to associate the antibacterial effect of aEVs to the
vesicular fractions (Figure S2f). Impairment of bacterial
growth in the presence of aEVs was not affected by DNAse
treatment but it was lost upon treatment by Triton X-100
demonstrating that the antibacterial effect was dependent on
intact vesicular structures (Figure S2g).
Tyrosine kinases are required for aEV formation
from human PMN
Outside-in signalling via activated integrins proceeds via tyro-
sine kinases, predominantly via the Src family kinases and Syk
tyrosine kinase [47]. We assessed the role of these signalling
elements in aEV formation by application of dasatinib, a tyr-
osine kinase inhibitor whose effects on human neutrophil
functions were investigated in detail [48]. Dasatinib did not
change spontaneous EV formation from resting cells but sig-
nificantly reduced aEV formation (Figure 2(e)).
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Dasatinib pretreatment also prevented the antibacterial
effect of EVs produced upon stimulation with fully opso-
nized particles (Figure 2(f)).
Receptor stimulation does not influence the size
and morphology of produced vesicles
To characterize the effect of receptor stimulation on phy-
sical properties of the produced EV population, we inves-
tigated their size and electron microscopic appearance
(Figure 3). Size distribution was first analysed by DLS
(Figure 3(a)). In DLS two major populations of particles
were revealed: one with a radius of 100 nm and a broader
onewith a radius of 200–700 nm. The latter size population
contains the EVs enumerated by our flow cytometry tech-
nique. Importantly this population disappeared upon treat-
ment with the detergent Triton X-100, confirming its
vesicular nature [49]. No significant size difference was
detected between different EV populations by DLS
(Figure 3(a) shows the curves only for sEV and aEV).
*
*** / #### ns / #
ns ns ***
a                                                                                        b                                   c
**** / ####
* / ## ns / ns
* / #### ** / ####
** / ####
Dasatinib - - + + Dasatinib - - + +
ns ns*
d                                             e                                                                              f
ns
** / ##
Figure 2. Complement receptor activation induces aEV production in human PMN. a. Quantification of EV production by flow
cytometry (FC, left axis) and protein amount measurement (right axis) after activation with non-opsonized (zEV), partially (abzEV) or
completely (aEV) opsonized zymosan. Data were compared by using two-way ANOVA coupled with Tukey’s post hoc test; n = 22, 26.
Level of significance is indicated by * for EV numbers and by # for protein amount. FC quantification of EV production by adherent
PMN on immune complex (IC) surface (b.) and on C3bi or bovine serum albumin (BSA) surface (c.). C3bi or bovine serum albumin (BSA)
surface. Data were compared using paired Student’s t-test, n = 8 and 4. d. Bacterial survival in the presence of different types of EVs
released from 5 × 106 PMN. Data were compared to sEV using RM one-way ANOVA coupled with Dunnett’s post hoc test; n = 11. e.
Quantification of EV production (left axis) and protein amount measurement (right axis) from PMN pretreated without or with
dasatinib. Data were compared by using two-way ANOVA coupled with Tukey’s post hoc test; n = 7,11. Level of significance is
indicated by * for EV numbers and by # for protein amount. f. Quantification of bacterial survival in the presence of aEV from PMN
preincubated without or with dasatinib. Data were compared to sEV using RM one-way ANOVA coupled with Dunnett’s post hoc test
n = 5.
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More detailed characterization was carried out by
electron microscopy. As demonstrated in Figure 3(b–f),
electron micrographs support the vesicular character of
all EV populations, but present heterogeneous mor-
phology and electron density. By measuring the area
of 400 intact vesicles the calculated diameter distribu-
tion is typical for medium-size EVs (Figure 3(g)). No
remarkable differences could be revealed either in the
morphological appearance or in size distribution of the
different vesicle populations produced spontaneously
(Figure 3(b,g)) or initiated by different receptor stimu-
lations (Figure 3(c–g)).
Cargo sorting into aEV is dependent on
complement receptor stimulation and signalling
Next we asked the question whether stimulation of the
different receptors only determined the number and func-
tion of produced EVs or they also affect cargo sorting into
the released vesicles. With this goal in mind, we investi-
gated the protein composition of the separated EV popula-
tions by proteomic analysis.We could identify a total of 206
proteins with 1% FDR. The label-free quantitative investi-
gation indicated that the largest fraction of the protein
content originated from granules of neutrophils, whereby
azurophilic and specific granules were more abundantly
represented than gelatinase granules or secretory vesicles
(Figure 4(a)). The non-granule fraction of proteins con-
sisted of cytoskeletal elements, cytosolic andmitochondrial
proteins (Supplementary Table 1).
The ratio of granular to non-granular proteins in sEV,
zEV and abzEV was around 50%. In contrast, additional
stimulation of complement receptors (resulting in aEV)
initiated a reproducible shift of the ratio to almost 60%.
The increase of the granular fraction was mainly due to
enrichment of proteins of azurophilic and specific gran-
ular origin (Figure 4(a)). Importantly, treatment with
dasatinib reduced the granule protein content of the
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Figure 3. Characterization of EVs derived of human PMN. a. Size distribution spectra of EVs measured by DLS. Broken line represents
0.1% Triton X-100 treated aEV. Signal above 1000 nm is due to zymosan contamination. Representative pictures of one out of three
similar experiments. Representative electron microscopic images of human sEV (b.), zEV (c.), abzEV (d.), aEV (e.), and aEV prepared
from dasatinib pretreated PMN (f.). Original magnification is 30,000×, representative pictures out of three similar experiments. g.
Size distribution spectra of human EVs based on electron microscopy images of one representative experiment, data originate from
400 EVs pro samples. The dotted line represents the possible limit of detectability by flow cytometry.
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generated EVs and diminished the proportion of proteins
issued from azurophilic and specific granules to the
values detected in sEVs.
We compared the amount of individual proteins in
aEV released from PMNpretreated with dasatinib or only
with vehicle (Figure 4(b–d)). The amount of the most
typical granule proteins was calculated from the label free
quantitative proteomic analysis (Figure 4(b)). With the
exception of matrix metalloprotease 9, which is typically
localized to gelatinase granules, all other granule proteins
are enriched in aEV as compared to sEV (represented by
the dotted line). Pretreatment of the cells with dasatinib
decreases the prevalence in aEVs of all proteins issued
from azurophilic or specific granules and in most cases
the amount is reduced to the value obtained in sEVs. We
investigated the enrichment of the two major granule
proteins, lactoferrin (from specific granules) and myelo-
peroxidase (from azurophilic granules) separately, by
Western blotting. Data shown in Figure 4(c,d) support
data of the proteomic analysis.
Characterization of murine PMN derived EVs
To elucidate the participation of specific molecules in EV
biogenesis, we turned to a mouse model. We isolated neu-
trophils from bone marrows and triggered EV production.
Similar to the data obtained with human PMN, non-opso-
nized particles initiated moderate EV-generation whereas
particles fully opsonized with murine serum induced signifi-
cant and consistent increase in EV production (Figure 5(a)).
Murine PMN-derived EVs were characterized by flow cyto-
metry, electron microscopy and DLS (Figure 5). They could
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Figure 4. Complement receptor activation induces enrichment of granule proteins in EVs. a. Label-free quantitative analysis of
granule protein presence in different EVs derived from human PMN. Analysis of one out of 2 similar experiments. b. Label-free
quantitative analysis of proteomics data on typical granule proteins of sEV and aEV obtained from untreated or dasatinib pretreated
human PMN. Dotted line represents sEV data as value 1; mean and individual values normalized to sEV; line represents mean ± SD.
c. Representative Western blot of lactoferrin (LTF), myeloperoxidase (MPO) and actin in EVs. Representative images out of 11 or 6
independent experiments. d. Densitometric analysis of the Western blots. LTF and MPO were related to actin. Data were compared
by using two-way ANOVA coupled with Tukey’s post hoc test; n = 11, 6. Level of significance is indicated by * for LTF and by # for
MPO.
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be labelled both by annexinV and by antibodies against
CD11b, CD18 and Ly6G, indicating that they are right-side
out neutrophil derived vesicles. Staining intensity with
annexinV or the antibodies against CD11b and CD18 was
comparable but Ly6G staining was less apparent (Figure S4).
Wherever it was possible, we used anti-CD11b labelling.
Electron micrographs support the vesicular character of
both the spontaneous and the activation induced EV popu-
lations (Figure 5(b,c)) and also show the presence of lipo-
philic particles of 10–15 nm radius, but without
distinguishable membrane and lumen structure (Figure 5
(c), black arrowheads). Thus, EVs derived from murine
PMN are smaller than their human counterparts (Figure 5
(d)), but present similar morphology in the electron micro-
graphs. In DLS two major populations of particles were
revealed (Figure 5(e)): one with a radius of 10–15 nm and
a broader onewith a radius of 100–200 nm. Importantly, this
population completely disappeared upon treatment with the
detergent Triton X-100, confirming its vesicular nature [49].
No size difference was detected between the different popu-
lations of EVs of murine neutrophils by DLS either. In the
following studies on the different geneticallymodifiedmouse
strains, EV production was triggered by fully opsonized
particles and referred to as CabzEV (reflecting the coactiva-
tion by complement, antibody and zymosan).
The complement receptor integrin Mac-1 but no Fc
receptors are essential for CabzEV formation from
murine neutrophils
First, we investigated the potential involvement of Fc
receptors in animals lacking the common γ chain of Fc
gamma receptors. This adapter molecule is required for
signal transduction via all different types of activating
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Figure 5. Characterization of murine PMN derived EVs. a. Quantification of EVs produced spontaneously (sEV) and after activation
with non-opsonized (zEV) or completely (CabzEV) opsonized zymosan. Data were compared to sEV using one-way ANOVA coupled
with Dunnett’s post hoc test; n = 32. Representative electron microscopic images of sEV (b.) and CabzEV (c.) prepared from WT
murine PMN. Original magnification is 30,000×. Representative pictures out of 3 similar experiments. d. Size distribution spectra of
murine EVs based on electron microscopy images, data originate from 200 EVs pro samples. The dotted line represents the possible
limit of detectability by flow cytometry. e. Size distribution spectra of EVs measured by DLS. Broken line represents 0.1% Triton X-
100 treated aEV. Signal above 1000 nm is due to zymosan contamination. Representative results out of 3 independent experiments.
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Fc gamma receptors present on murine neutrophils
[28]. As shown in Figure 6(a), neutrophils from Fc
receptor γ chain knock out-animals produced
CabzEV similar to neutrophils from WT mice.
Next, we tested the potential role of neutrophil
integrins in EV formation. All three integrins (Mac-1,
LFA, gp150,95) identified in neutrophils are composed
of the same β chain (CD18) complexed to a specific α
chain [31]. First, we tested neutrophils from animals
deficient in the common β chain, CD18. As shown in
Figure 6(b), genetic deletion of CD18 completely abol-
ished CabzEV production, whereas release of sEV was
not significantly altered. To decipher the participation
of the three known integrins, we next investigated
neutrophils from mice deficient in the specific α
chain of Mac-1 (CD11b). Generation of CabzEV was
decreased to a similar extent in CD11b deficient neu-
trophils (Figure 6(c)) as it was observed in cells lacking
CD18 (Figure 6(b)). Thus, the integrin Mac-1, which
also serves as CR3, the dominant complement receptor
on neutrophils has the key role in CabzEV formation
in vitro.
Mac-1 is also involved in production of activated
EV in murine peritoneal cavity
To obtain information on the in vivo relevance of our ex
vivo data, we tested activated EV formation in a murine
model of inflammation. Zymosan was injected intraperito-
neally and cells and EVs were detected in the lavage fluid.
Twohours after zymosan injection, a significant increase of
the PMNnumberwas observed in the lavage fluid, whereas
the number ofmonocytes and lymphocytes remainedunal-
tered (Figure 7(a)). At a later time point (4 h) all leukocyte
types were increased (not shown). Thus in the critical
experiments lavage fluid was collected 2 h following zymo-
san injection. Next we compared the presence of neutro-
phils and EVs in the lavage fluid from WT and CD11b
deficient animals (Figure 7(b,c)). Mac-1 integrin was
shown to play an important role in adherence of neutro-
phils to endothelial cells and other surfaces, but several
previous studies reported that transvascular migration
was – unexpectedly – enhanced in its absence [50–53]. In
accordance with these findings, in the experiments pre-
sented in Figure 7(b) migration of CD11b deficient neu-
trophils to the inflamed peritoneum was approximately
twofold higher than the migration rate of WT cells. In the
absence of CD11b, the specific α chain of Mac-1, CD18 is
still expressed in complex with another α chain in LFA.
CD18 was detected on neutrophils from CD11b KO mice,
but its level was slightly lower than on cells from WT
animals [52]. In order to exclude any uncertainty due to
altered CD18 expression in CD11bKO animals, we carried
out the labelling of EVs harvested from the peritoneum
parallel with anti-CD18 antibody or with annexinV. In
Figure 7(c), we show both results. In spite of the higher
PMN count in the peritoneum, activated EV production of
CD11b deficient cells did not exceed that of WT neutro-
phils (Figure 7(c)). The number of activated EVs produced
per PMNupon zymosan triggeringwas approximately 50%
a                                              b                                             c
WT            CD18 KO WT           CD11b KO
*** **
WT             FcRγ KO
ns
ns
** ns
ns
**
** ns
ns
*
Figure 6. Mac-1/CR3 has a key role in CabzEV production in murine PMN. Comparison of sEV and CabzEV production of WT vs. FcRγ-
chain KO (a.), CD18 KO (b.), and CD11b KO (c.) murine PMN. Labelling was carried out in the experiments of panels b. and c. with
annexinV. Data were compared using one-way ANOVA coupled with Bonferroni’s post hoc test; n = 27, 22, 21.
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lower in the CD11b-deficient animals than in the controls
(Figure 7(d,e)). Thus, Mac-1 seems to be implicated in
activated EV generation also under in vivo conditions.
Discussion
The presented experiments indicate the role of Mac-1/
CR3 in initiating the formation of antibacterial EVs
from neutrophilic granulocytes. In human neutrophils,
only under conditions of costimulation of complement
receptors could we observe the characteristic triad of (i)
strong increase in the number and protein content of
the produced EVs, (ii) reproducible enrichment of
proteins issued from azurophilic and specific granules
and (iii) appearance of the capability to impair bacterial
growth. Similar to human neutrophils, significant
increase of EV formation could be achieved upon sti-
mulation with fully opsonized particles also in murine
cells. Generation of these CabzEVs was completely
blocked in the absence of either chain of the Mac-1
integrin. In contrast, stimulation of Fc receptors alone
(on IC surface, Figure 2(b)) or in combination with
PRR (in the soluble system, Figure 2(a)) did not result
in generation of aEVs. In the murine system lack of
signal transduction via Fc receptors did not affect
CabzEV generation. Whereas our experiments do not
formally exclude the possibility of participation of Fc
receptors in triggering of aEV formation, they do not
provide experimental support for it. Stimulation of
unidentified PRRs did induce a slight increase in EV
number, but these vesicles had no enrichment of gran-
ule proteins as compared to sEV and were devoid of
antibacterial capacity; however, their costimulatory role
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cannot be excluded. Previous investigations showed
that soluble proinflammatory mediators such as
FMLF, TNFα, CXCL12 and LPS were not able to initi-
ate aEV production either [18].
Several lines of control experiments support that the
antibacterial effect of aEVs can indeed be attributed to
vesicles as opposed to aggregates of antibacterial pro-
teins cosedimented with the aEVs. (i) Separation of
vesicular from non-vesicular material by SEC indicated
that antibacterial effect was only associated with the
vesicular fraction (Figure S2f), (ii) in the aEV prepara-
tion protein content was increased only in the vesicular
fraction (Figure S2e), (iii) the antibacterial effect was
lost upon disruption of the vesicular structure by
Triton X-100 (Figure S2g).
Neutrophils are short living cells which can die or
form NETs upon stimulation [43]. In control experi-
ments, we verified that the stimulation applied in this
study did not lead either to impairment of cell viability
or to NET formation (Figure S3). In line with these
results, the proteomic analysis indicated no or only
inconsistent amount of histones in the EV preparations
sedimented by centrifugation (Table S1). Last but not
least the antibacterial effect of aEVs was not altered by
DNAse treatment (Figure S2g) although PMA-induced
NET formation was inhibited by DNAse (Figure S3g–
h). All these data support that the observed impairment
of bacterial growth is not the consequence of NET
formation.
We applied zymosan induced peritonitis as an ani-
mal inflammation model to test the validity of our
results obtained on isolated neutrophils. Only cell
and EV numbers in the lavage fluid could be deter-
mined, hence factors such as adherence to the perito-
neum or uptake of EVs into different cells could not be
taken into account. Zymosan induces the transvascular
migration of all leukocyte types, although in different
time frame. We carried out peritoneal lavage two
hours after zymosan injection, i.e. at a time point
where neutrophils represent the dominant cell type.
The poor detectability of the neutrophil-specific mar-
ker Ly6G on neutrophil-derived vesicles did not allow
the unambiguous identification of the cellular origin of
the harvested EVs. However, the significantly
decreased proportion of EVs to PMN in the lavage
fluid observed in CD11b (Mac-1) deficient animals is
in agreement with our suggestion on the role of Mac-1
in enhanced release of EVs from zymosan-activated
neutrophils.
It could be argued that opsonized particles represent
a complex and very strong stimulus for neutrophils and
it is the strength of the stimulus that alters vesicle
formation similar to graded exocytosis that was
shown to depend on the intensity of calcium signalling
[54]. In this respect, it should be considered that zymo-
san plus antibody opsonized particles represent as
strong stimulus for superoxide production as are the
fully opsonized particles (Figure S3n). Nevertheless,
only fully opsonized particles induce the formation of
aEV (Figure 2(d)). Furthermore, we have investigated
previously the properties of EVs triggered by the stron-
gest, though pharmacological stimulus, phorbol-miris-
tate-acetate (PMA) [18]. The number and granule
protein content of PMA-initiated EVs was lower than
that of EVs triggered by opsonized particles, they did
not form large aggregates with bacteria and did not
significantly interfere with bacterial growth. We thus
suggest that the Mac-1 initiated signalling pathway
represents the major factor in antibacterial EV
formation.
The fact that specific receptors can be pinpointed as
triggers for aEV production demonstrates that aEV
formation is an active and directed cellular process as
opposed to random release of particles or decomposi-
tion of cells. It should however be noted that genetic
deletion of specific molecules did not affect the spon-
taneous production of EVs (sEV) and the applied inhi-
bitor was also not able to decrease aEV formation
below the level of sEV. Apparently, there are two
parallel processes: the spontaneous, constitutive pro-
duction – by hitherto unidentified mechanism – of
sEVs that do not interact with bacteria. On top of
this, the process initiated by Mac-1 leads to generation
of a large number of aEVs enriched in proteins origi-
nating from the primary and secondary granules of
neutrophils and capable of impairing bacterial growth.
In our earlier studies, we presented evidence that the
antibacterial capacity of the EVs triggered by opsonized
particles did not depend on the increased number of
the produced vesicles, but on the altered properties of
aEVs [18,22]. In the present work, we identified Mac-1
as a dominant cell surface receptor that is involved in
biogenesis of distinct EV population with altered cargo
and development of antibacterial capacity.
Mac-1 has over 40 identified ligands, structurally
very different molecules present on the endothelial sur-
face, on extracellular matrix proteins, on soluble
plasma proteins or even on microorganisms [55]. The
binding sites for the complement factor C3bi, fibrino-
gen, neutrophil inhibitory factor, GPIbα and CD40L
have been mapped in the ligand-binding I-domain of
the LM chain. The binding sites for these ligands are
overlapping but not identical and some ligands were
shown to function as biased agonists [55,56]. Several
ligands could potentially stimulate aEV production in
addition to complement components. Mac-1
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stimulation could thus alter the functional properties of
EVs released from neutrophils under different condi-
tions, where the involvement of the integrin has been
already shown, such as adhesion, migration or phago-
cytosis. In fact, a previous publication [14] reported
that neutrophils adherent to HUVEC cells released
higher number of EVs that were able to produce an
elevated amount of leukotriene B4 as compared to EVs
produced by suspended neutrophils. As multiple Mac-1
ligands have been described on endothelial cells [56],
adhesion of neutrophils to HUVEC cells could possibly
involve Mac-1 activation. Potential antibacterial effect
was not investigated in that study.
On the basis of our data we raise the concept that
EVs are “tailor-made” whereby their cargo and func-
tional properties are adapted to the prevailing condi-
tions of the environment. In the presented case the
primary event is the appearance of the foreign particles
– e.g. bacteria – that become opsonized and the com-
plement receptor initiates the generation of specialized
EVs endowed with the capacity to impair the growth of
the invader. In our view, Mac-1 represents the first
example – followed probably by many others – as a
specific cell surface molecule involved in selective gen-
eration of EVs to achieve optimal cellular responses to
environmental cues.
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